In a developing story out of Alberta, Sam Jaber, a recently appointed member of the Invest Alberta Corp. board, has stepped back from his responsibilities following a search of his accounting firm by the RCMP. This action coincides with an ongoing investigation into alleged procurement irregularities within the province’s healthcare sector.
Background of the Investigation
The scrutiny surrounding Alberta’s procurement practices came to light in February 2023, when allegations surfaced regarding inflated contracts awarded to private companies, compounded by claims of political interference at Alberta Health Services (AHS). The RCMP confirmed in March 2025 that they are actively investigating these allegations, focusing on several contracts, including a significant $70 million agreement awarded to MHCare Medical Corp. for the importation of children’s medication from Turkey. Alarmingly, it has been reported that only a fraction of the ordered medication actually reached the province.
The investigation has raised questions about accountability within the healthcare system, particularly concerning the relationships between government officials and private entities. Jaber’s firm, Jaberson & Associates, was searched by police last week, intensifying the scrutiny on his role within Invest Alberta.
Jaber’s Leave of Absence
In light of the investigation, Jaber has voluntarily taken a temporary leave from his position on the Invest Alberta board. His biography on the organisation’s website now includes a note stating that he has informed the board of his decision to step back until he can fully commit to the organisation’s goals. The board chair has accepted this request.
Matthew Nathanson, Jaber’s lawyer, expressed confidence that the investigation will exonerate his client, asserting that Jaber has acted with integrity throughout this process. “We are confident that a fair and balanced investigation will reach this conclusion,” Nathanson stated in an email.
Political Reactions and Implications
The unfolding events have not gone unnoticed in the political arena. Naheed Nenshi, the Leader of the New Democratic Party, questioned the nature of Jaber’s leave, suggesting it should have been mandated rather than voluntary. In response, Joseph Schow, Government House Leader, confirmed that Jaber “stepped down” while highlighting Invest Alberta’s ongoing efforts to attract investment to the province.
The Premier’s office has remained tight-lipped about the situation, with spokesman Sam Blackett stating that commenting on an active investigation would be inappropriate. The lack of clarity regarding Jaber’s status has raised eyebrows, particularly given the timing of his appointment and the serious nature of the allegations.
Future of Invest Alberta
As Jaber steps away, the remaining board members are poised to continue their critical work in fostering economic growth and attracting investment to Alberta. An official statement from Invest Alberta reaffirmed their commitment to supporting the province’s economic diversification during this turbulent period.
The investigation’s outcome could have significant implications for both Jaber and the broader governance of Alberta’s health procurement processes. The Premier’s decision to appoint Jaber in 2023 has also come under scrutiny, with past interactions between Jaber and government officials being examined as part of the inquiry.
Why it Matters
The situation surrounding Sam Jaber and the investigation into Alberta’s procurement practices highlights the intricate relationship between government and private sector dealings within the healthcare system. The implications of this case extend beyond Jaber himself, as it raises pressing questions about transparency, accountability, and the integrity of public contracts. As the investigation unfolds, its findings could reshape how procurement is managed in Alberta and restore or erode public trust in government institutions.
